Your Complete Guide to Global Clinical Research and GCP Compliance
Using Metrics to Refine RACT, CtQ, KRIs and QTLs Over Time Using Metrics to Refine RACT, CtQ, KRIs and QTLs Over Time In the realm of pharmaceutical clinical trials, the effective management and evaluation of risk are paramount to ensure compliance with regulatory requirements and the overall success of the study. Key performance metrics such…
Read More “Using Metrics to Refine RACT, CtQ, KRIs and QTLs Over Time” »
RBM Maturity Models and Benchmarking Against Industry Peers RBM Maturity Models and Benchmarking Against Industry Peers As clinical trials evolve, the need for effective risk-based monitoring (RBM) strategies has become paramount. The goal of RBM is to focus resources on the most significant risks associated with clinical trials, ensuring that data integrity and patient safety…
Read More “RBM Maturity Models and Benchmarking Against Industry Peers” »
Vendor and Cloud Provider Considerations for Long-Term Storage Vendor and Cloud Provider Considerations for Long-Term Storage The proper management of data storage in clinical trials is essential for ensuring compliance with regulatory requirements and maintaining data integrity. As the clinical research landscape evolves, understanding the implications of vendor and cloud provider choices for long-term data…
Read More “Vendor and Cloud Provider Considerations for Long-Term Storage” »
Data Integrity and Security Controls for Archived Clinical Information Data Integrity and Security Controls for Archived Clinical Information The management of clinical trial data integrity and security is paramount for ensuring compliance with regulatory frameworks across the US, UK, and EU. In this step-by-step guide, we will outline the best practices for maintaining security controls…
Read More “Data Integrity and Security Controls for Archived Clinical Information” »
Case Studies: Missing Data That Changed Regulatory Outcomes Case Studies: Missing Data That Changed Regulatory Outcomes Missing data is an inevitable challenge in clinical trials, particularly in oncology clinical research, where complex treatment regimens and patient-related factors contribute to incomplete datasets. The consequences of missing data can influence regulatory outcomes significantly. This article provides a…
Read More “Case Studies: Missing Data That Changed Regulatory Outcomes” »
Comparing Pre- and Post-RBM Performance Across Trials and Portfolios Comparing Pre- and Post-RBM Performance Across Trials and Portfolios Introduction to Risk-Based Monitoring (RBM) The landscape of clinical trials is undergoing a transformation with the adoption of Risk-Based Monitoring (RBM) methodologies. Traditional monitoring methods often lead to inefficiencies, resource wastage, and increased timelines, which can impede…
Read More “Comparing Pre- and Post-RBM Performance Across Trials and Portfolios” »
<!– Metadata Dashboards for RBM Effectiveness: What to Track Monthly and Quarterly –> Dashboards for RBM Effectiveness: What to Track Monthly and Quarterly In the realm of clinical trials, particularly for covid clinical trials, the adoption of Risk-Based Monitoring (RBM) is essential in ensuring that trial operations operate efficiently while maintaining compliance with regulatory standards….
Read More “Dashboards for RBM Effectiveness: What to Track Monthly and Quarterly” »
Defining Retention Periods for Different Document and Data Types Retention periods for documents and data generated during clinical trials are dictated by regulatory requirements and institutional policies. These periods ensure compliance, facilitate audits, protect institutional interests, and preserve the integrity of trial data. This guide will offer a systematic approach to establishing retention periods for…
Read More “Defining Retention Periods for Different Document and Data Types” »
Ensuring Readability and Accessibility of Archived Data Over Decades Ensuring Readability and Accessibility of Archived Data Over Decades Archived data retention is a crucial aspect of conducting pharma clinical trials. It is vital not only for compliance with regulatory demands but also for the integrity and reliability of scientific findings. This tutorial provides a comprehensive…
Read More “Ensuring Readability and Accessibility of Archived Data Over Decades” »
Visualizing Missing Data Patterns for CRAs, Clinicians and Statisticians Visualizing Missing Data Patterns for CRAs, Clinicians and Statisticians In the realm of clinical trials, addressing missing data is crucial to the integrity and interpretability of trial results. Among various methodologies employed to manage missing data, visualization techniques stand out as effective tools for clinical research…
Read More “Visualizing Missing Data Patterns for CRAs, Clinicians and Statisticians” »
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.